Oyster .05 g/mL
Crassostrea virginica · SOLUTION · Greer Laboratories, Inc.
Oyster is a solution containing crassostrea virginica at .05 g/mL, taken intradermal. Manufactured by Greer Laboratories, Inc..
Key Facts
- Brand Name
- Oyster
- Generic Name
- Crassostrea virginica
- NDC Code (Product)
22840-5774- Manufacturer
- Greer Laboratories, Inc.
- Strength
- .05 g/mL
- Dosage Form
- SOLUTION
- Route
- INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA101833
- Marketing Start
- 09/15/1981
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Thisproductisuable for men.Long em use helpsnouish the kidneys antvila energyenhancephyskcal igoimprowve thequalty of sexual le,imprvemornimg erecions and hardnes,andeeve postcoita fatigue. This product ispurely derived from botanical extracls, making it suitable for long-term use withno reported adverse side effects
Dosage & Administration
Dosage:2-4 tablets per day
Warnings
Not suitable for individuals under 18years of age Do not use if you have a seafood allergy.
Frequently Asked Questions
What is Oyster used for?
Oyster contains Crassostrea virginica. It is a solution taken intradermal. Consult your doctor for specific uses.
Is Oyster a controlled substance?
Oyster is not classified as a controlled substance by the DEA.
What is the generic name for Oyster?
The generic name for Oyster is Crassostrea virginica. There are 1 other brand versions of Crassostrea virginica.
What is the NDC code for Oyster .05 g/mL?
The NDC (National Drug Code) for Oyster .05 g/mL is 22840-5774, listed by Greer Laboratories, Inc..